Trafficking and proteolytic processing of APP

Author(s): Haass C, Kaether C, Thinakaran G, Sisodia S

Abstract

Accumulations of insoluble deposits of amyloid β-peptide are major pathological hallmarks of Alzheimer disease. Amyloid β-peptide is derived by sequential proteolytic processing from a large type I trans-membrane protein, the β-amyloid precursor protein. The proteolytic enzymes involved in its processing are named secretases. β- and γ-secretase liberate by sequential cleavage the neurotoxic amyloid β-peptide, whereas α-secretase prevents its generation by cleaving within the middle of the amyloid domain. In this chapter we describe the cell biological and biochemical characteristics of the three secretase activities involved in the proteolytic processing of the precursor protein. In addition we outline how the precursor protein maturates and traffics through the secretory pathway to reach the subcellular locations where the individual secretases are preferentially active. Furthermore, we illuminate how neuronal activity and mutations which cause familial Alzheimer disease affect amyloid β-peptide generation and therefore disease onset and progression.

Similar Articles

Alzheimer's  disease: the challenge of the second century

Author(s): Holtzman DM, Morris JC, Goate AM

Epidemiology of  Alzheimer disease

Author(s): Reitz C, Brayne C, Mayeux R

Trafficking regulation of proteins in Alzheimer's disease

Author(s): Jiang S, Li Y, Zhang X, Bu G, Xu H, et al.

Efficient inhibition of the Alzheimer's disease  beta-secretase by membrane targeting

Author(s): Rajendran L, Schneider A, Schlechtingen G, Weidlich S,  Ries J, et al.

Crystal structure of an active form of BACE1, an enzyme responsible for  amyloid beta protein production

Author(s): Shimizu H, Tosaki A, Kaneko K, Hisano T, Sakurai T, et al. 

Aβ-degrading enzymes: potential for treatment of Alzheimer disease

Author(s): Miners JS, Barua N, Kehoe PG, Gill S, Love S

Nonsteroidal anti-inflammatory drugs repress beta-secretase gene  promoter activity by the activation of PPARgamma

Author(s): Sastre M, Dewachter I, Rossner S, Bogdanovic N, Rosen E,  et al.

Cholesterol reduction impairs exocytosis of synaptic vesicles

Author(s): Linetti A, Fratangeli A, Taverna E, Valnegri P, Francolini  M, et al.

Critical time window of neuronal cholesterol  synthesis during neurite outgrowth

Author(s): Fünfschilling U, Jockusch WJ, Sivakumar N, Möbius W,  Corthals K, et al.

Cholesterol  homeostasis in neurons and glial cells

Author(s): Vance JE, Hayashi H, Karten B

Lipoproteins and their receptors in the central nervous system

Author(s): Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH